Evidence map›Paper›PMID 39157630›Full record

ArticleEJHaem2024

IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.

Chien-Chin Lin, Chi-Yuan Yao, Yu-Hung Wang, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chien-Chin LinDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.ORCID https://orcid.org/0000-0001-7160-2285
Chi-Yuan YaoDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.ORCID https://orcid.org/0000-0001-5052-9445
Yu-Hung WangDivision of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.ORCID https://orcid.org/0000-0002-6090-9000
Yueh-Chwen HsuDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.
Chang-Tsu YuanGraduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.
Tsung-Chih ChenGraduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.
Chia-Lang HsuDepartment of Medical Research National Taiwan University Cancer Center Taipei Taiwan.
Sze-Hwei LeeDivision of Cellular Therapy Department of Integrated Diagnostics and Therapeutics National Taiwan University Hospital Taipei Taiwan.ORCID https://orcid.org/0000-0003-3500-0513
Jhih-Yi LeeDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.
Pin-Tsen ShihDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.
Chein-Jun KaoDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.
Po-Han ChuangDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.
Yuan-Yeh KuoTai-Cheng Stem Cell Therapy Center National Taiwan University Taipei Taiwan.
Hsin-An HouDivision of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.
Wen-Chien ChouDepartment of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.
Hwei-Fang TienDivision of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.ORCID https://orcid.org/0000-0002-1384-5593

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: In this study, we aimed to elucidate the roles of Results: We found that thrombopoietin (TPO)-overexpressed Conclusion: Overall, our findings showed that

Indexed as

IDH2 mutationmyelofibrosisS100a8/a9TPO

Identifiers

PMID39157630
PMCPMC11327712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.